Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Studies Examine Peripheral Nervous System Disease in Lupus Patients

Linda Childers  |  Issue: November 2020  |  November 12, 2020

Of the more than 1,800 patients followed in our multi-ethnic longitudinal study, more than 8% experienced some type of PNS disease. —John Hanly, MD, FRCPC

Quality of Life Affected

“These aren’t minimal events,” Dr. Hanly stressed. “Patients who experience these symptoms report a lower quality of life and physical function, even when we took other factors into account.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Although Dr. Hanly notes that, encouragingly, PNS symptoms resolved over time with appropriate treatment, but patients who were diagnosed with SLE at an older age, had previous neuropathy or more SLE disease activity experienced a longer recovery.

As a result, Dr. Hanly says it’s reasonable to request a neurological exam for older SLE patients who may be at risk of PNS.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Although not all PNS manifestations occur due to lupus, we found that most do,” Dr. Hanly says. “While this is a challenging aspect of lupus, the good news is that a substantial number of patients improved with appropriate care.”

Dr. Hanly hopes the results from this study will provide a benchmark for the assessment of future treatments.

Italian Study Supports Findings

Another recent study, “Peripheral Nervous System Involvement in Systemic Lupus Erythematosus: A Retrospective Study on Prevalence, Associated Factors and Outcome,” conducted by Italian researchers, looked at SLE patient records from two referral centers between 2000 and 2014.2

As in Dr. Hanly’s study, researchers confirmed that damage accrual and advanced age are potential risk factors for PNS in lupus patients.

The researchers found that out of 1,224 patients, PNS was experienced in 85 patients, primarily women. Ninety-seven PNS events in total were reported. In two cases PNS occurred before the diagnosis of SLE, in 26 patients PNS manifestations took place at the onset of the disease, and in 57 patients PNS occurred more than three months after an SLE diagnosis.

The study also determined that high blood pressure and livedo reticularis may be risk factors for PNS in lupus patients. Smoking, secondary Sjögren’s syndrome and diabetes were also more commonly found in patients with PNS.


Linda Childers is a health writer located in the San Francisco Bay Area.

References

  1. Hanly JG, Li Q, Su L, et al. Peripheral nervous system disease in systemic lupus erythematosus: Results from an international inception cohort study. Arthritis Rheumatol. 2020 Jan;72(1):67–77.
  2. Bortoluzzi A, Piga M, Silvagni E, et al. Peripheral nervous system involvement in systemic lupus erythematosus: A retrospective study on prevalence, associated factors and outcome. Lupus. 2019 Apr;28(4):465–474.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:central nervous systemperipheral nervous systemquality of life

Related Articles
    Lupus often presents with a butterfly rash.

    Top 12: Research in Systemic Lupus Erythematosus at a Glance

    November 18, 2021

    Dr. Pisetsky’s picks for the top research in lupus presented at ACR Convergence 2021.

    New Study Examines Cerebrovascular Events in Lupus Patients

    May 17, 2019

    Stroke and transient ischemia are the most common cerebrovascular events in lupus patients, and a new study has found most of these occurrences can be attributed to lupus itself rather than other causes. The study, published in the October 2018 issue of Arthritis Care & Research, looked at the frequency, association and outcomes of cerebrovascular…

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences